WEDNESDAY, April 24, 2019 -- Personalizing breast cancer treatment based on Oncotype DX recurrence scores could result in small decreases in costs in the initial 12 months of care, according to a study published online April 24 in the Journal of the...
Original Article: Personalizing Breast Cancer Tx Could Cut Initial Costs of Care